Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tuning BMP-Regulated Cell Differentiation in the Aortic Media by Mutating Matrix Gla Protein.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

General Oxidative Chemical Activation of Neutral Exciton Emission in Colloidal MoS<sub>2</sub> Monolayers.

Journal of the American Chemical Society·2026
Same author

Designing and mapping cascade catalysis pathway for balanced polysulfide conversion in Li-S batteries.

Nature communications·2026
Same author

Rejuvenated Hematopoietic Stem and Progenitor Cell-Engineered CAR-Armored Natural Killer T Cells for Malignant Pleural Mesothelioma.

Research (Washington, D.C.)·2026
Same author

Electrically functionalized body surface for deep-tissue bioelectrical recording.

Nature biomedical engineering·2026
Same author

Cation-Limited Hydroxide Anion Diffusion Drives Asymmetric Hydrogen Kinetics on Transition-Metal Decorated Platinum Surface.

Journal of the American Chemical Society·2026

Related Experiment Video

Updated: Jun 12, 2025

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation
10:16

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation

Published on: October 12, 2018

8.0K

Biomimetic cell stimulation with a graphene oxide antigen-presenting platform for developing T cell-based therapies.

Enbo Zhu1,2,3,4, Jiaji Yu2, Yan-Ruide Li2

  • 1Department of Materials Science and Engineering, University of California, Los Angeles, Los Angeles, CA, USA.

Nature Nanotechnology
|September 23, 2024
PubMed
Summary

Researchers developed a graphene oxide platform to mimic T cell interactions, significantly boosting CAR T cell production and function. This innovation enhances cancer immunotherapy manufacturing by improving T cell proliferation and reducing reliance on external growth factors.

More Related Videos

Preparation and Characterization of Graphene-Based 3D Biohybrid Hydrogel Bioink for Peripheral Neuroengineering
10:17

Preparation and Characterization of Graphene-Based 3D Biohybrid Hydrogel Bioink for Peripheral Neuroengineering

Published on: May 16, 2022

2.2K
Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.5K

Related Experiment Videos

Last Updated: Jun 12, 2025

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation
10:16

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation

Published on: October 12, 2018

8.0K
Preparation and Characterization of Graphene-Based 3D Biohybrid Hydrogel Bioink for Peripheral Neuroengineering
10:17

Preparation and Characterization of Graphene-Based 3D Biohybrid Hydrogel Bioink for Peripheral Neuroengineering

Published on: May 16, 2022

2.2K
Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.5K

Area of Science:

  • Immunology
  • Materials Science
  • Biotechnology

Background:

  • Chimeric antigen receptor (CAR)-engineered T cells are crucial for cancer therapy.
  • Current CAR T cell manufacturing lacks effective immunological synapse formation.
  • This limitation hinders optimal T cell expansion and function.

Purpose of the Study:

  • To develop a novel platform for improved CAR T cell manufacturing.
  • To mimic in vivo immunological synapses for enhanced T cell activation.
  • To increase CAR T cell proliferation, potency, and gene-engineering efficiency.

Main Methods:

  • Development of a flexible graphene oxide antigen-presenting platform (GO-APP).
  • Decoration of graphene oxide with anti-CD3 (αCD3) and anti-CD28 (αCD28) antibodies (GO-APP3/28).
  • In vitro assessment of T cell interactions with GO-APP3/28, including proliferation, multifunctionality, and gene-engineering efficiency.

Main Results:

  • GO-APP3/28 successfully mimicked in vivo immunological synapses.
  • Achieved remarkable T cell proliferation and preserved T cell multifunctionality and potency.
  • Enhanced CAR gene-engineering efficiency by over fivefold compared to standard protocols.
  • Stimulated autocrine interleukin-2 (IL-2) production, reducing reliance on external IL-2 supplementation.

Conclusions:

  • The GO-APP3/28 platform offers a superior method for CAR T cell manufacturing.
  • This approach improves T cell expansion and function for cancer immunotherapy.
  • It presents a potential strategy for IL-2 independent T cell culture.